Cingulate begins Phase 3 tests of novel treatment for ADHD
January 09, 2023 at 08:25 AM EST
Cingulate's technology will let patients receive treatment ADHD treatment without second doses, boosters to get through the day.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |